Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
Le dernier exercice comptable publié pour cette entreprise remonte à 2021. Les données ci-dessous peuvent ne plus refléter sa situation actuelle.

THE ELEMENT BIOTECHNOLOGY : revenue, balance sheet and financial ratios

THE ELEMENT BIOTECHNOLOGY is a French company founded 4 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in GRENOBLE (38000), this company of category PME shows in 2021 a net income negative of -2 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-08-08

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Synthèse

Santé financière : Fragile

Signal structurel : exploitation déficitaire (EBE négatif).

In summary, THE ELEMENT BIOTECHNOLOGY is currently loss-making, which weighs on its accounts. Its financial structure is solid, with debt well contained relative to its sector.

Financial history - THE ELEMENT BIOTECHNOLOGY (SIREN 908502909)
Indicator 2021
Revenue N/C
Net income -1 886 €
EBITDA -1 886 €
Net margin N/C

Revenue and income statement

In 2021, THE ELEMENT BIOTECHNOLOGY records a net loss of 2 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2021) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-1 886 €

EBIT (2021) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-1 886 €

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-1 886 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 4%. Compared with its sector, this ratio places the company among the best positioned (sector median: 28.7%). Financial autonomy (= Equity / Total assets x 100) reaches 96%. Compared with its sector, this ratio places the company among the best positioned (sector median: 43.4%).

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3.56%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

96.16%

Repayment capacity (2021) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-0.91

Solvency indicators evolution
THE ELEMENT BIOTECHNOLOGY

Sector positioning

Debt ratio
3.56% 2021
Q1: 4.73%
Med: 28.68%
Q3: 78.36%
Excellent

In 2021, the debt ratio of THE ELEMENT BIOTECHNOLOGY (3.6%) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
96.16% 2021
Q1: 22.91%
Med: 43.4%
Q3: 63.96%
Excellent

In 2021, the financial autonomy of THE ELEMENT BIOTECHNOLOGY (96.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 238.26. Compared with its sector, this ratio places the company among the best positioned (sector median: 2.5).

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

238.26

Interest coverage (2021) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
THE ELEMENT BIOTECHNOLOGY

Sector positioning

Liquidity ratio
238.26 2021
Q1: 1.61
Med: 2.53
Q3: 3.98
Excellent

In 2021, the liquidity ratio of THE ELEMENT BIOTECHNOLOGY (238.26) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.0x 2021
Q1: 0.0x
Med: 0.64x
Q3: 2.6x
Average

In 2021, the interest coverage of THE ELEMENT BIOTECHNOLOGY (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 33 days. Excellent situation: suppliers finance 33 days of the operating cycle (retail model).

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

33 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
THE ELEMENT BIOTECHNOLOGY

Positioning of THE ELEMENT BIOTECHNOLOGY in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare THE ELEMENT BIOTECHNOLOGY with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Top companies in Fabrication de matériel médico-chirurgical et dentaire

Largest companies by revenue in the sector Fabrication de matériel médico-chirurgical et dentaire:

Top companies in Isere

Largest companies by revenue in the department Isere:

Voir le classement complet du département Isere

Frequently asked questions about THE ELEMENT BIOTECHNOLOGY

What is the revenue of THE ELEMENT BIOTECHNOLOGY ?

The revenue of THE ELEMENT BIOTECHNOLOGY is not publicly disclosed (confidential accounts filed with INPI).

Is THE ELEMENT BIOTECHNOLOGY profitable?

THE ELEMENT BIOTECHNOLOGY recorded a net loss in 2021.

Where is the headquarters of THE ELEMENT BIOTECHNOLOGY ?

The headquarters of THE ELEMENT BIOTECHNOLOGY is located in GRENOBLE (38000), in the department Isere.

Where to find the tax return of THE ELEMENT BIOTECHNOLOGY ?

The tax return of THE ELEMENT BIOTECHNOLOGY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does THE ELEMENT BIOTECHNOLOGY operate?

THE ELEMENT BIOTECHNOLOGY operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.